scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.AJOG.2004.12.023 |
P698 | PubMed publication ID | 16098864 |
P50 | author | Diana W. Bianchi | Q15989750 |
Roberto Romero | Q42734915 | ||
Antonio Farina | Q46209842 | ||
Ricardo Gomez | Q57064410 | ||
Tinnakorn Chaiworapongsa | Q69022472 | ||
P2093 | author name string | Nicola Rizzo | |
Erik S LeShane | |||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | risk factor | Q1475848 |
P304 | page(s) | 421-425 | |
P577 | publication date | 2005-08-01 | |
P1433 | published in | American Journal of Obstetrics and Gynecology | Q4744256 |
P1476 | title | High levels of fetal cell-free DNA in maternal serum: a risk factor for spontaneous preterm delivery. | |
P478 | volume | 193 |
Q54986845 | A Profile of Dennis Lo, DM, DPhil, FRCP, FRCPath, FRS. |
Q40544172 | Absolute first trimester cell-free DNA levels and their associations with adverse pregnancy outcomes |
Q36041489 | Alterations in maternal-fetal cellular trafficking after fetal surgery |
Q36143042 | An Advanced Model to Precisely Estimate the Cell-Free Fetal DNA Concentration in Maternal Plasma |
Q35756049 | Biochemical markers for prediction of preclampsia: review of the literature. |
Q89660275 | Cell-Free Fetal DNA Increases Prior to Labor at Term and in a Subset of Preterm Births |
Q38541725 | Cell-Free Fetal DNA, Telomeres, and the Spontaneous Onset of Parturition |
Q40707142 | Cell-free DNA as a potential marker to predict carbon tetrachloride-induced acute liver injury in rats. |
Q34607066 | Cell-free fetal DNA and cell-free total DNA levels in spontaneous abortion with fetal chromosomal aneuploidy |
Q35110814 | Cell-free fetal DNA and pregnancy-related complications (review) |
Q50356518 | Cell-free fetal DNA and spontaneous preterm birth. |
Q46934240 | Cell-free fetal DNA in maternal circulation after chorionic villous sampling |
Q39778751 | Cell-free fetal nucleic acids as prenatal biomarkers |
Q91773787 | Cell-free mitochondrial DNA in human follicular fluid: a promising bio-marker of blastocyst developmental potential in women undergoing assisted reproductive technology |
Q38918315 | Circulating Maternal Total Cell-Free DNA, Cell-Free Fetal DNA and Soluble Endoglin Levels in Preeclampsia: Predictors of Adverse Fetal Outcome? A Cohort Study |
Q35204477 | Circulating cytokines and alarmins associated with placental inflammation in high-risk pregnancies |
Q54941025 | Decreased DNA methylation of a CpG site in the HBAP1 gene in plasma DNA from pregnant women. |
Q38550197 | Detecting cancer biomarkers in blood: challenges for new molecular diagnostic and point-of-care tests using cell-free nucleic acids |
Q38178293 | Diagnostic accuracy of non-invasive fetal RhD genotyping using cell-free fetal DNA: a meta analysis |
Q92110121 | Effect of cell-free fetal DNA on spontaneous preterm labor |
Q46320319 | Elevated plasma levels of hypermethylated RASSF1A gene sequences in pregnant women with intrahepatic cholestasis |
Q34558118 | Epigenetic approaches for the detection of fetal DNA in maternal plasma |
Q36372845 | Evidence of perturbations of the cytokine network in preterm labor |
Q36654711 | Fetal DNA in maternal plasma: progress through epigenetics |
Q41912007 | Fetal and Placental DNA Stimulation of TLR9: A Mechanism Possibly Contributing to the Pro-inflammatory Events During Parturition |
Q47579497 | Implications of failure to achieve a result from prenatal maternal serum cell-free DNA testing: a historical cohort study |
Q37337106 | Increased maternal T cell microchimerism in the allogeneic fetus during LPS-induced preterm labor in mice |
Q91591027 | Inflammation-mediated generation and inflammatory potential of human placental cell-free fetal DNA |
Q38613379 | Integrative single-cell and cell-free plasma RNA transcriptomics elucidates placental cellular dynamics |
Q35099257 | Mass spectrometric based analysis, characterization and applications of circulating cell free DNA isolated from human body fluids |
Q34519955 | Maternal T cells limit engraftment after in utero hematopoietic cell transplantation in mice |
Q33838736 | Maternal-fetal cellular trafficking: clinical implications and consequences |
Q52632153 | Maternal-fetal cross talk through cell-free fetal DNA, telomere shortening, microchimerism, and inflammation. |
Q28081268 | Molecular Regulation of Parturition: The Role of the Decidual Clock |
Q35040804 | Non-invasive prenatal testing of trisomy 18 by an epigenetic marker in first trimester maternal plasma |
Q26774719 | Parturition dysfunction in obesity: time to target the pathobiology |
Q37822751 | Placental microparticles, DNA, and RNA in preeclampsia |
Q37278804 | Potential markers of preeclampsia--a review |
Q36117899 | Prediction, prevention and personalisation of medication for the prenatal period: genetic prenatal tests for both rare and common diseases |
Q35071019 | Prematurity: present and future |
Q34314824 | Preterm labor: one syndrome, many causes |
Q38598829 | Programmed Fetal Membrane Senescence and Exosome-Mediated Signaling: A Mechanism Associated With Timing of Human Parturition |
Q33838434 | Quantification of cell-free DNA in normal and complicated pregnancies: overcoming biological and technical issues |
Q37000825 | Recent advances in non-invasive prenatal DNA diagnosis through analysis of maternal blood. |
Q26991553 | Review: cell-free fetal DNA in the maternal circulation as an indication of placental health and disease |
Q92538569 | The Cellular Transcriptome in the Maternal Circulation During Normal Pregnancy: A Longitudinal Study |
Q36700837 | The preterm parturition syndrome. |
Q26995586 | Tracking fetal development through molecular analysis of maternal biofluids |
Q54159132 | Unmethylated-maspin DNA in maternal plasma is associated with severe preeclampsia. |
Search more.